Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4567871
Max Phase: Preclinical
Molecular Formula: C65H75Br4N11O2S
Molecular Weight: 1074.46
Molecule Type: Unknown
Associated Items:
ID: ALA4567871
Max Phase: Preclinical
Molecular Formula: C65H75Br4N11O2S
Molecular Weight: 1074.46
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[n+]1ccc(-c2c3nc(c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](CCCCCCCCCCCCNC(=O)CCCC[C@@H]5SC[C@@H]6NC(=O)N[C@@H]65)cc4)c4nc(c(-c5cc[n+](C)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1.[Br-].[Br-].[Br-].[Br-]
Standard InChI: InChI=1S/C65H72N11O2S.4BrH/c1-73-36-26-45(27-37-73)60-49-18-20-51(67-49)61(46-28-38-74(2)39-29-46)53-22-24-55(69-53)63(56-25-23-54(70-56)62(52-21-19-50(60)68-52)47-30-40-75(3)41-31-47)48-32-42-76(43-33-48)35-15-11-9-7-5-4-6-8-10-14-34-66-59(77)17-13-12-16-58-64-57(44-79-58)71-65(78)72-64;;;;/h18-33,36-43,57-58,64H,4-17,34-35,44H2,1-3H3,(H2-2,66,67,68,69,70,71,72,77,78);4*1H/q+1;;;;/p-1/b60-49-,60-50-,61-51-,61-53-,62-52-,62-54-,63-55-,63-56-;;;;/t57-,58-,64-;;;;/m0..../s1
Standard InChI Key: XCOXJCDLJYDSQM-YCJAHECSSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1074.46 | Molecular Weight (Monoisotopic): 1073.5804 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ferino A, Nicoletto G, D'Este F, Zorzet S, Lago S, Richter SN, Tikhomirov A, Shchekotikhin A, Xodo LE.. (2020) Photodynamic Therapy for ras-Driven Cancers: Targeting G-Quadruplex RNA Structures with Bifunctional Alkyl-Modified Porphyrins., 63 (3): [PMID:31930916] [10.1021/acs.jmedchem.9b01577] |
Source(1):